Amphenol 8-K 确认已执行的2:1拆股完成及拆股后股息机械调整，无新增信息

----- tm2624775d1_8k.htm -----
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
September 2, 2026
AMPHENOL CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
1-10879
22-2785165
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
358 Hall Avenue
,
Wallingford
,
Connecticut
06492
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including
area code: (
203
)
265-8900
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A Common Stock, $0.001 par value
APH
New York Stock Exchange
3.375% Senior Notes due 2029
APH29B
New York Stock Exchange
3.125% Senior Notes due 2032
APH32
New York Stock Exchange
3.875% Senior Notes due 2034
APH34A
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
¨
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.
¨
Item 8.01
Other Events.
On August 6, 2026, Amphenol Corporation (the “Company”)
announced that its Board of Directors approved the third quarter 2026 dividend on its Class A Common Stock (the “Common Stock”)
in the amount of $0.25 per share. The dividend will be paid on October 14, 2026 to shareholders of record as of September 22, 2026.
On August 6, 2026, the Company also announced the approval of a two-for-one
stock split of the Common Stock in the form of a stock dividend to be distributed on September 2, 2026, to holders of record of the Common
Stock at the close of business on August 17, 2026.
The two-for-one stock split referenced above has now been effected.
In light of the stock split, the dividend to be paid on October 14, 2026 to shareholders of record as of September 22, 2026 will now be
$0.125 per share.
This Current Report on Form 8-K may include forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of
1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and other related
laws, which relate to future events and are subject to risks and uncertainties. The forward-looking statements, which address the Company’s
expected business and financial performance and financial condition, among other matters, may contain words and terms such as: “anticipate,”
“believe,” “continue,” “could,” “estimate,” “expect,” “forecast,”
“guidance,” “intend,” “look ahead,” “may,” “ongoing,” “optimistic,”
“plan,” “potential,” “predict,” “project,” “seek,” “should,” “target,”
“will,” or “would” and other words and terms of similar meaning. Forward-looking statements by their nature address
matters that are, to different degrees, uncertain, such as statements about expected earnings, revenues, growth, liquidity, effective
tax rate, interest rates, the expected timing for the closing of certain acquisitions or other matters. A further description of these
uncertainties and other risks can be found under the caption “Risk Factors” in Part I, Item 1A and elsewhere in the Company’s
Annual Report on Form 10-K for the year ended December 31, 2025, as well as other reports filed with the Securities and Exchange Commission,
including, but not limited to, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. These or other uncertainties could cause
the Company’s actual future results to be materially different from those expressed in any forward-looking statements. The Company
undertakes no obligation to update or revise any forward-looking statements except as required by law.
The information set forth in this Item 8.01 is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed
incorporated by reference in any filing by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly
set forth by specific reference in such filing.
Signature
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AMPHENOL CORPORATION
By:
/s/ Lance E. D’Amico
Lance E. D’Amico
Executive Vice President, Secretary and General Counsel
Date: September 4, 2026